CompuGROUP and Knappschaft Bahn See Launch Pilot Programme

CompuGROUP Holding AGCompuGROUP Holding AG, the e-health service company with the broadest reach among service providers world-wide, is now supporting the integrated treatment of patients suffering from Type 2 diabetes mellitus through its subsidiary GIV. Client Knappschaft Bahn See expects the programme to provide more effective patient care and reduce costs significantly.

In the fourth quarter of 2008, Knappschaft Bahn See and the CompuGROUP subsidiary Gesellschaft für angewandte integrierte Versorgungsformen (GiV) mbH in the Saarland launched an innovative, fully practicable, integrated treatment programme: prosper Versorgungsmanagement Diabetes. The goal is to optimize treatment in order to improve the health of manifest diabetics and risk patients on a sustained basis. Apart from this top-priority medical goal, the programme is also expected to reduce the consequential costs of diabetes, which account for up to 80% of total treatment costs for these patients.

The foundation of the prosper programme is a health-care network established by Knappschaft and composed of family doctors, specialists and hospitals in a given region. The prosper Saar health-care network consists of over 300 physicians, of whom 50 are now participating in the interdisciplinary, cross-sector prosper Versorgungsmanagement Diabetes programme.

The heart of prosper Versorgungsmanagement Diabetes consists of a central, indication-based case file and an innovative diagnostic and treatment path derived from data contained in the file - both elements developed by CompuGROUP. All relevant information is entered in the file by participating physicians. It includes comprehensive treatment data on Type 2 diabetes patients as well as information about identified risk patients. On the basis of this medical data, the treatment path provides specific guideline-oriented recommendations for treatment teams at the moment a medical decision needs to be made. The diabetes mellitus path was developed by the medical team at CompuGROUP in consultation with the renowned expert Prof. Dr. Werner Scherbaum of Düsseldorf. "Our goal is to offer doctors only those 'bits of information' they really need - at precisely the right moment and integrated directly into the physician's workflow", explains Frank Ladendorf, Managing Director of GiV.

Prof. Dr. med. Werner Scherbaum, Director of the Endocrinology, Diabetology and Rheumatology Clinic at the Düsseldorf University Hospital, goes one step further: "The prosper Versorgungsmanagement Diabetes programme responds to the repeatedly expressed appeal for a practicable diagnostic and treatment system controlled primarily by family physicians. Specialist treatment can be integrated without difficulty. Making the best use of existing resources, developing them through innovation and thus doing more for patients and their health - these are the primary objectives of prosper Versorgungsmanagement Diabetes."

Frank Ladendorf emphasizes the potential savings for health insurers: "We are already seeing evidence that prosper Versorgungsmanagement Diabetes enhances the efficiency of patient treatment while ensuring quality and cost-effectiveness on a sustainable basis. Our software makes a valuable contribution in that context. I'm sure", Ladendorf adds, "that other health insurers will soon be using intelligent-software-aided systems of this kind to increase efficiency as well."

"We hope to find out", says Hans Adolf Müller, Health Management Director at Knappschaft Bahn See, "whether this innovative decision-support system will enable us to help our policyholders more effectively and to provide more systematic support to treating physicians and their teams." CompuGROUP has proven to be a strong partner. As the market leader, CompuGROUP has broad, central access to practising physicians thanks to the widespread use of its physicians' information system.

According to Frank Ladendorf, "Treatment management systems of this kind work only if they are accepted by physicians. We gain that acceptance by integrating the system into existing workflows and by ensuring complete transparency - with respect to prescriptions, for example." The pilot project is scheduled to run until the end of 2009, after which it will be evaluated for the purpose of assessing the practicability and the added benefits of this form of integrated treatment. If the positive results shown thus far are confirmed, the programme will be launched on a broad basis and expanded to include other guideline-oriented patient paths for other widespread diseases in 2010.

Related news articles:

About CompuGROUP Holding AG
CompuGROUP is one of the leading e-health companies worldwide. Its software products, designed to support all medical and organizational activities in doctors' offices and hospitals, its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. The services of CompuGROUP are based on its unique customer base of around 326,000 doctors, dentists, hospitals and networks as well as other service providers. CompuGROUP is the e-health company with the biggest coverage among e-health service providers worldwide. The company operates in 14 European countries, Malaysia, Saudi Arabia, South Africa and in the USA and currently employs around 2,700 people.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...